.
Native vaccine trials start in July.
Bharat Biotech acquired an edge in the race among a few entities in the nation and a number of more globally to all set a vaccine for COVID-19 when the Drug Controller General of India (DCGI) cleared its item for human scientific trials.
The partnership with the Indian Council of Medical Research (ICMR)- National Institute of Virology (NIV) was instrumental in the advancement of the vaccine, Chairman and Managing Director Krishna Ella stated on Monday. The trials of Covaxin, the vaccine, will start next month.
The proactive assistance and guidance from the Centra